AbbVie | Omløpsmidler

Current Assets Endring Dato
AbbVie USD 33.22B 4.37B 2023-09
ALKERMES USD 1.46B 67.43M 2023-09
Amgen USD 30.33B 18.14B 2023-12
AstraZeneca USD 22.5B 338M 2023-09
Bristol-Myers Squibb USD 27.63B 442M 2023-09
Eisai JPY 659.27B 19.2B 2023-09
Eli Lilly USD 23.01B 1.68B 2023-09
Gilead Sciences USD 16.45B 474M 2023-12
GlaxoSmithKline GBP 21.24B 1.89B 2023-09
Merck USD 31.95B 1.98B 2023-09
Neurocrine Biosciences USD 1.65B 153.3M 2023-09
Pacira USD 509.99M 62.74M 2023-12
Perrigo USD 2.77B 7.7M 2023-09
Pfizer USD 74.01B 665M 2023-09
Regeneron Pharmaceuticals USD 24.49B 5.85B 2023-12
Roche Holding CHF 30.98B 2.84B 2023-06
UCB EUR 3B 303M 2023-06
Ultragenyx Pharmaceutical USD 599.19M 102.95M 2023-09
United Therapeutics USD 3.55B 92.1M 2023-12
Vertex Pharmaceuticals USD 14.7B 822.9M 2023-09
Zoetis USD 6.34B 121M 2023-12



AbbVie Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.